Tirzepatide ships as a lyophilized (freeze-dried) powder because the dry state is far more stable than solution. Reconstitution converts it into a working research stock for in-vitro assays.
General reconstitution workflow
The same principles that apply to any freeze-dried peptide apply here — see how to reconstitute a lyophilized peptide. Diluent is typically bacteriostatic water, added slowly down the vial wall rather than directly onto the powder cake to reduce shear and foaming.
Concentration is a research variable
Stock concentration in a lab is chosen by the experimental design and expressed in molar or mass-per-volume terms for in-vitro use — this is not human dosing. For identity and strength assurance behind those calculations, see tirzepatide purity testing.
After reconstitution
Once in solution, tirzepatide is less stable than the dry powder; keep it cold, dark, and aliquoted to avoid repeated freeze-thaw — details in tirzepatide storage and stability and general peptide storage.
Product page: Tirzepatide research vials.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.